Chemomab jumps on positive liver scarring trial results
Chemomab Therapeutics (Nasdaq: CMMB), which is developing treatments for fibro-inflammatory (scarring) diseases, rose 14% on Friday and is up...
Results
Calyxo Announces New ASPIRE 1-Year Study Results
Calyxo, Inc., a medical device company developing innovative solutions for patients with kidney stones, has announced positive new study results...
Calyxo Announces New ASPIRE 1-Year Study Results with CVAC System in Kidney Stone Clearance Indicating a Positive Clinical and Health Economic Impact in the Treatment of Urolithiasis
CVAC System (Photo: Business Wire)CVAC System ProcedureMulti-Center ASPIRE 1-Year Study Results Show Healthcare Consumption Events are Significantly Lower after SURE...
:max_bytes(150000):strip_icc()/VWH-GettyImages-1483000268-84def6d7c6fe4e5b9099ca9cf6cec909.jpg "How Liver Metastasis Is Treated")
